Company Filing History:
Years Active: 2012
Title: Marie-Lyne Alcaraz: Innovator in Pharmaceutical Chemistry
Introduction
Marie-Lyne Alcaraz is a notable inventor based in Great Britain, recognized for her contributions to pharmaceutical chemistry. She has made significant strides in the development of innovative compounds aimed at treating chronic obstructive pulmonary disease (COPD). Her work exemplifies the intersection of scientific research and practical application in medicine.
Latest Patents
Marie-Lyne Alcaraz holds a patent for the invention titled "Tosylate Salt Of A 5-Pyrazolyl-2-Pyridone Derivative, Useful In The Treatment Of COPD." This patent details a compound known as 6-Methyl-5-(I-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate. The patent outlines processes for preparing this salt and its novel crystalline form, along with pharmaceutical compositions that incorporate this form and its therapeutic applications.
Career Highlights
Throughout her career, Marie-Lyne Alcaraz has focused on the synthesis and development of pharmaceutical compounds. Her innovative approach has led to advancements in treatments for respiratory diseases, showcasing her commitment to improving patient outcomes through scientific research.
Collaborations
Marie-Lyne has collaborated with esteemed colleagues, including Lars-Erik Briggner and Per Tomas Klingstedt. These partnerships have enhanced her research efforts and contributed to the successful development of her patented compounds.
Conclusion
Marie-Lyne Alcaraz is a pioneering inventor whose work in pharmaceutical chemistry has the potential to significantly impact the treatment of COPD. Her innovative contributions and collaborations highlight the importance of research in advancing medical science.